CXCL17 and breast cancer: The models including 4T1 and MDA-MB-231 breast cancer used in our study are triple-negative breast cancer; therefore, further study is required to clarify possible roles of ER, PR, or Her2/neu in the regulation of CXCL17 in breast cancer.